Sequence to Solution
Our research operates at the intersection of molecular engineering, nanotechnology, and computational biology. We design, develop, and validate solutions using in vitro, organoid and in vivo models.
Capabilities
Publications
-
![]()
Pathways for macrophage uptake of cell-free circular RNAs
June 6, 2024
-
![]()
Circular RNA vaccine induces potent T cell responses
May 8, 2023
-
![]()
Engineering circular RNA for enhanced protein production
July 18, 2022
-
![]()
Structured elements drive extensive circular RNA translation
October 21, 2021
-
![]()
N6-Methyladenosine Modification Controls Circular RNA Immunity
October 3, 2019
-
![]()
Sensing Self and Foreign Circular RNAs by Intron Identity
July 20, 2017
Patent Portfolio
The Stanford RNA Medicine Program deploys proprietary IP as the foundation for our internal clinical candidates while simultaneously generating novel, mission-specific intellectual property for our global collaborators.
Our framework ensures that foundational delivery components are utilized to maximize patient impact across both academic and industry-led initiatives.
-
Patent Number: US11814627B2
-
Patent Number: US11685924B2
Patent Number: US11560567B2
Application Number: US20230407317A1 -
Application Number: US20260015627A1
-
Application Number: US20220288176A1
Request a Meeting
Seeking a collaborative partner for molecular design or LNP optimization?